[Progress in the study on roles of cathepsin in hypertension]

Area of Science:

• Cardiovascular physiology and pathophysiology
• Enzymology and molecular biology
• Hypertension research

Background:

• Cardiovascular remodeling and dysfunction are key in hypertension development.
• Cathepsins, enzymes in various tissues, influence hypertension pathogenesis.
• Cathepsins are implicated in renin-angiotensin system activation, matrix degradation, and cell proliferation/hypertrophy.

Purpose of the Study:

• To explore the role of cathepsins in hypertension.
• To investigate cathepsins as potential biomarkers for hypertension.
• To identify novel therapeutic strategies targeting cathepsins for hypertension treatment.

Main Methods:

• Review of clinical studies on cathepsins and hypertension.
• Analysis of research on cathepsin functions and mechanisms in cardiovascular disease.
• Investigation of cathepsin involvement in renin-angiotensin system, smooth muscle cell proliferation, and myocyte hypertrophy.

Main Results:

• Cathepsins are significantly involved in the development of hypertension.
• Clinical studies identify cathepsins as viable biomarkers for hypertension.
• Emerging research highlights cathepsins' potential in novel hypertension treatments.

Conclusions:

• Cathepsins play a crucial role in cardiovascular remodeling and dysfunction leading to hypertension.
• Cathepsins serve as important biomarkers for hypertension diagnosis and prognosis.
• Targeting cathepsin pathways offers promising new avenues for effective hypertension therapy.